CBOE vs CME

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

CBOE

44.7
AI Score
VS
CBOE Wins

CME

37.7
AI Score

Investment Advisor Scores

CBOE

45score
Recommendation
HOLD

CME

38score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric CBOE CME Winner
Forward P/E 21.978 21.7865 CME
PEG Ratio 2.3852 4.68 CBOE
Revenue Growth 22.9% 0.8% CBOE
Earnings Growth 50.2% 2.5% CBOE
Tradestie Score 44.7/100 37.7/100 CBOE
Profit Margin 26.7% 63.4% CME
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL CBOE

Relative Price Performance (Last 90 Days)

CBOE 1M: +5.6% · 3M: -14.5% CME 1M: +8.1% · 3M: -4.9%

Current Technical Phase

CBOE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 58

RSI (14): 57.5 · Price: $300.74

CME

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 65

RSI (14): 64.7 · Price: $274.98

Fundamentals Snapshot

Metric CBOE CME
Market Cap
Forward P/E 19.8 21.3
Trailing P/E 22.9 22.6
Revenue (TTM)
Revenue Growth 0.2% 0.0%
Gross Margin 0.5% 1.0%
Operating Margin 0.3% 0.7%
EPS 12.83 11.97
Dividend Yield 0.01% 0.02%

Frequently Asked Questions

Based on our detailed analysis, CBOE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.